Quarterly Journal Volume 53, Issue 4
In This Section
The Quarterly Journal is dedicated to presenting materials relating to intellectual property matters and is published four times per year. Editorial Board members (all of whom are lawyers) are selected based upon demonstrated interest and experience, and student staff members are selected from the students of the GWU Law School.
QJ 53.4 - DMC-AI: An AntIvenom
Wade Witcher
The Digital Millennium Copyright Act (DMCA) emerged as a cornerstone of early Internet policy, designed to foster electronic commerce through safe harbor provisions for online platforms. However, after nearly three decades, the Internet landscape has transformed dramatically—now dominated by sophisticated AI algorithms that automatically curate, promote, and moderate user content across social media platforms. Although AI has generated unprecedented user engagement and revenue streams, it has also intensified copyright infringement challenges, leaving copyright holders overburdened with enforcement efforts.
In this context, the technology that threatens copyright becomes its potential savior—analogous to how snake venom becomes essential in developing antivenom. Despite posing significant intellectual property rights challenges, AI offers powerful enforcement mechanisms to address these issues.
QJ 53.4 - Compounded Drugs: An Uprise of Trademark Infringement Lawsuits
Calling for More FDA Regulation
Vanessa Sabrina Bittar
COMPOUNDED DRUGS: AN UPRISE OF TRADEMARK INFRINGEMENT LAWSUITS CALLING FOR MORE FDA REGULATION
Demand for GLP-1 medications has surged, driven by their use in diabetes treatment and off-label weight loss. With increasing demand, manufacturers of the Food and Drug Administration (“FDA”) approved drugs Ozempic, Wegovy, Mounjaro, and Zepbound have had a hard time producing enough medicine to meet consumer demand. Supply shortages prompted the FDA to allow compounding pharmacies to produce copies of these drugs, which are not FDA-approved, meaning they lack safety, quality, and efficacy testing. The rise in compounded drugs has sparked trademark infringement and false advertising claims by original manufacturers, like Novo Nordisk and Eli Lilly, who allege that affiliation with the compounded drugs harm their brands. This Note discusses the need for enhanced regulatory measures to better control the advertising and labeling of compounded drugs, proposing that the FDA is given more authority to expand on its current regulation and require clear disclaimers to protect consumers and trademark rights.
QJ 53.4 - Domestic Industry: Why the Analysis Should Change with the Times
Hank Stein
DOMESTIC INDUSTRY: WHY THE ANALYSIS SHOULD CHANGE WITH THE TIMES
The modern American industrial landscape is vastly different from when the Smoot-Hawley Tariff Act of 1930 first established Section 337 investigations. In the years since 1930, ITC Commissioners have disagreed over whether the economic prong of the domestic industry analysis should adapt to the modern economic landscape. Recent cases at the ITC and the Federal Circuit have shown that it is time for the Commission to once again reckon with this question. This note suggests that the ITC should fully adopt the Federal Circuit's recent ruling in Lashify, Inc. and implement the holistic "as-a-whole" analysis for domestic industry. This would include expenses centered on non-traditional industries such as sales and marketing, bringing American intellectual property rights enforcement into the modern age.
QJ 53.4 - Just a Generative AI User, Standing in Front of a Copyright Troll, Asking
it to Love Her: Generative AI, Copyright Trolls, and the Statutory Damages
Regime
Louise Strange
Copyright trolls have been on the rise for the last few decades, capitalizing on the statutory damages scheme offered in the Copyright Act. While the main arena for copyright trolls has generally been within peer-to-peer file sharing, the inception and popularization of generative artificial intelligence (“Generative AI”) may present a new frontier for copyright trolls. With the massive amounts of data contained in training sets for Generative AI models, some degree of copyright infringement in both the input and output of these engines is all but assured. End-users may not know it, but their actions in using Generative AI may open them up to the predatory litigation tactics of these trolls. The solution can be found in taking away the monetary incentive for copyright trolls to behave as they do; by applying a presumption of innocent infringement, end-users of generative artificial intelligence may be better shielded from forced settlements, while willful infringers can still be held accountable.
QJ Volume 53 Article and Author Index
Upcoming Events
-
2026 Patent Prosecution Bootcamp - Arlington, VA
March 4 to 6, 2026 | Up to 1235 minutes, including 60 Ethics minutes
-
AIPLA CLE Webinar: Damages 2025 Year-in-Review: Lessons and Litigation Strategies
March 11, 2026 2:00 PM to 3:30 PM | Eligible for up to 90 Mins CLE
-
AIPLA LinkedIn Live: What the 2025 AIPLA Economic Survey Reveals About IP Practice Today
March 12, 2026 12:00 PM to 12:45 PM
-
2026 Women in IP Global Networking Event
April 16, 2026
The annual Global Networking Event connects intellectual property practitioners from around the world for a day of networking, education, and creating meaningful connections. This year’s theme, Rooted in Real - Women in IP Redefining the Narrative, is an opportunity for the AIPLA Women in IP Law Committee to celebrate authentic experiences, foster genuine connections, and showcase the real stories of women shaping the field of intellectual property law. -
Careers in IP
April 22, 2026 12:30 PM to 1:30 PM | No CLE

